Current situation of viral hepatitis in Egypt
- 15 May 2021
- journal article
- review article
- Published by Wiley in Microbiology and Immunology
- Vol. 65 (9) , 352-372
Abstract
An estimated 8–10 million people suffer from viral hepatitis in Egypt. Hepatitis A virus (HAV) and hepatitis E virus (HEV) are the major causes of viral hepatitis in Egypt as 50% or more of the Egyptian population are already exposed to HAV infection by the age of 15. In addition, over 60% of the Egyptian population test seropositive for anti‐HEV in the first decade of life. HEV mainly causes self‐limiting hepatitis; however, cases of fulminant hepatitis and liver failure were reported in Egypt. Hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV) are the main causes of chronic hepatitis, liver cirrhosis, and liver cancer (hepatocellular carcinoma [HCC]) in Egypt. Globally, Egypt had the highest age‐standardized death rate due to cirrhosis from 1990 to 2017. The prevalence rate of HBV (1.3%–1.5%) has declined after national infantile immunization. Coinfection of HBV patients with HDV is common in Egypt because HDV antibodies (IgG) vary in range from 8.3% to 43% among total HBV patients. After the conduction of multiple national programs to control HCV infection, a lower rate of HCV prevalence (4.6%) was recently reported. Data about the incidence of HCV after treatment with direct antiviral agents (DAAs) are lacking. An HCC incidence of 29/1000/year in cirrhotic patients after DAA treatment is reported. A higher rate of infiltrative pattern among HCC patients after DAA treatment is also recognized. Viral hepatitis is one of the major public health concerns in Egypt that needs more attention and funding from health policymakers.Keywords
Funding Information
- Japan Society for the Promotion of Science (18F18098, 19K07586)
- Japan Agency for Medical Research and Development (20fk0310104j0904, 20fk0310109j0404)
This publication has 196 references indexed in Scilit:
- Occult Hepatitis B Virus Infection in Anti-HBs-Positive Infants Born to HBsAg-Positive Mothers in ChinaPLOS ONE, 2013
- The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesisBMC Infectious Diseases, 2013
- Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!Asian Journal of Transfusion Science, 2012
- Hepatitis delta virusThe Lancet, 2011
- Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, EgyptAsian Journal of Transfusion Science, 2011
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialThe Lancet, 2010
- Evidence of intense ongoing endemic transmission of hepatitis C virus in EgyptProceedings of the National Academy of Sciences, 2010
- Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in EgyptJournal of Clinical Virology, 2009
- Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infectionVirology Journal, 2007
- Genotypes and phylogenetic characterization of hepatitis B and delta viruses in EgyptJournal of Medical Virology, 2003